Startup Constant Therapy snags seed funding for brain rehab iPad app

Boston's Constant Therapy is at work on a cloud-based iPad app for patients undergoing brain rehabilitation, and the startup has wrapped up its first funding round. With the undisclosed cash infusion, the company plans to finish development and launch its product, which allows clinicians to design rehab programs for victims of traumatic brain injury, who follow along on an easy-to-use platform, the company said. More

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.